Antifungal prophylaxis following heart transplantation: systematic review

Summary Patients with heart transplantation have a high incidence of infectious complications, especially fungal infections. The aim of the systematic review was to determine the best pharmacological strategy to prevent fungal infections among patients with heart transplant. We searched the PubMed a...

Full description

Saved in:
Bibliographic Details
Published in:Mycoses 2014-07, Vol.57 (7), p.429-436
Main Authors: Uribe, Luis G., Cortés, Jorge A., Granados, Carlos E., Montoya, José G.
Format: Article
Language:English
Subjects:
Antifungal agents
Antifungal Agents - therapeutic use
Aspergillus
heart transplantation
Heart Transplantation - adverse effects
heart trasplantation
Humans
Mycoses - etiology
Mycoses - prevention & control
Risk Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Summary Patients with heart transplantation have a high incidence of infectious complications, especially fungal infections. The aim of the systematic review was to determine the best pharmacological strategy to prevent fungal infections among patients with heart transplant. We searched the PubMed and Embase databases for studies reporting the effectivenesss of pharmacologic strategies to prevent fungal infections in adult patient with a heart transplant. Our search yielded five studies (1176 patients), four of them with historical controls. Two studies used inhaled amphotericin B deoxycholate, three used itraconazole and one used targeted echinocandin. All studies showed significant reduction in the prophylaxis arm. Different products, doses and outcomes were noted. There is a highly probable benefit of prophylaxis use, however, better studies with standardised doses and comparators should be performed.
ISSN:0933-7407
1439-0507
DOI:10.1111/myc.12179